More News

29 Aug 2018 Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray
28 Aug 2018 LifeMax Acquires Worldwide Right to Clinical Stage Orphan Asset
28 Aug 2018 Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets
27 Aug 2018 CENTOGENE and Evotec Sign Global Strategic Partnership on Drug Discovery Projects in Rare Genetic Diseases
26 Aug 2018 Novaremed announces that it has raised CHF 6 million to prepare for a Phase 2b clinical study in Diabetic Neuropathic Pain
26 Aug 2018 JW Pharmaceutical signs global out-licensing agreement for their novel atopic dermatitis drug candidate, JW1601, with LEO Pharma, a global leader in medical dermatology
26 Aug 2018 Forbius (Formation Biologics) Awarded $18.8 Million Grant by the Cancer Prevention and Research Institute of Texas
24 Aug 2018 Rakuten Aspyrian Raises $150 Million in Series C Financing
24 Aug 2018 bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies
24 Aug 2018 GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
22 Aug 2018 Evotec and Novo Nordisk form strategic research alliance in diabetes and obesity
22 Aug 2018 Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
20 Aug 2018 Harbour BioMed Announces Global Strategic Partnership with Kelun-Biotech to Develop and Commercialize A167, An Anti-PD-L1 Antibody, for Treatment of Cancer
20 Aug 2018 PCI Biotech initiates research collaboration with Bavarian Nordic
18 Aug 2018 HitGen Announces Innovative Drug Discovery Research Collaboration with LG Chem by Applying DNA-Encoded Technology
17 Aug 2018 Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins
15 Aug 2018 RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality and Persistence of T Cells and NK Cells for the Advancement of Immuno-Oncology Therapeutics for Solid Tumors
15 Aug 2018 Haplogen enters into a collaboration with Bayer
13 Aug 2018 Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax
13 Aug 2018 Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis
13 Aug 2018 Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency
11 Aug 2018 Astellas Announces Acquisition of Quethera
10 Aug 2018 OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
09 Aug 2018 Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash
09 Aug 2018 Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple CNS-targeted Gene Therapy programs and Access to Important Gene Therapy Talent and Tools

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up